| dc.contributor | | es-ES |
| dc.creator | Cabrera, Maria Elena; Jefe Sección Hematología, Hospital del Salvador | |
| dc.creator | Silva, Guillermo; Residente Hematología, Hospital del Salvador | |
| dc.creator | Soto, Andrés; Residentes Medicina Interna, Hospital del Salvador | |
| dc.creator | Roselló, Rodrigo; Residentes Medicina Interna, Hospital del Salvador | |
| dc.creator | Castro, Constanza; Residentes Medicina Interna, Hospital del Salvador | |
| dc.creator | Martinez, Virginia; Instituto Anatomía Patológica. | |
| dc.creator | Ballesteros, Juan; Sección Infectología, Hospital del Salvador | |
| dc.creator | Blamey, Rodrigo; Sección Infectología, Hospital del Salvador | |
| dc.creator | Garreaud, Claudia; Sección Infectología, Hospital del Salvador | |
| dc.date | 2012-01-10 | |
| dc.date.accessioned | 2019-11-11T18:26:37Z | |
| dc.date.available | 2019-11-11T18:26:37Z | |
| dc.identifier | http://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/954 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/110779 | |
| dc.description | HIV-RELATED LYMPHOMA IN A PUBLIC HOSPITAL IN CHILE. ANALYSIS OF 55 CASES Background: Cancer is the third cause of death in patients infected with human immunodeficiency virus (HIV) and lymphoma is the most common type. Aim: To describe the clinical characteristics, histology, risk factors and prognosis of these patients, in a Chilean public hospital in Chile. Material and methods: Records of 55 patients (45 males) aged between 23 and 67 years with lymphoma and HIV positive serology, diagnosed between 1992-2008, were reviewed. Results: Six patients (11%) had Hodgkin lymphoma (HL) and the rest, non-Hodgkin lymphoma (NHL). B-cell phenotype constituted 83.7% of NHL cases. The most common subtype was diffuse large B cell lymphoma in 24 cases (49%), followed by Burkitt lymphoma in 12 cases (24.5%), T and T/NK cell lymphoma in 8 cases (16.3%) and plasmablastic lymphoma in 5 cases (10.2%). Thirty five patients (64%) underwent curative intended chemotherapy (CT) concomitantly with highly active antiretroviral therapy (HAART). Three year survival of the whole cohort was 27%. By multivariate analysis, the most important prognostic factors for long term survival, were complete response to CT, (p | es-ES |
| dc.language | es | |
| dc.publisher | Revista Médica de Chile | es-ES |
| dc.source | Revista Médica de Chile; Vol. 140, núm. 2 (2012): FEBRERO 2012 | es-ES |
| dc.source | 0034-9887 | |
| dc.subject | Antiretroviral therapy, highly active; HIV; Hodgkin disease; Lymphoma, non-Hodgkin | es-ES |
| dc.title | Linfoma relacionado a infección por virus de la inmunodefciencia humana en un hospital público de Santiago, Chile. | es-ES |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
| dc.type | | es-ES |
